{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:16:36Z","timestamp":1762100196404},"reference-count":56,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":4232,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1111\/j.0022-202x.2004.22525.x","type":"journal-article","created":{"date-parts":[[2004,5,7]],"date-time":"2004-05-07T14:19:11Z","timestamp":1083939551000},"page":"1302-1309","source":"Crossref","is-referenced-by-count":23,"title":["Reduced Expression of Insulin-Like Growth Factor-Binding Protein-3 (IGFBP-3) in Squamous Cell Carcinoma Complicating Recessive Dystrophic Epidermolysis Bullosa"],"prefix":"10.1016","volume":"122","author":[{"given":"Rajeev","family":"Mallipeddi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vesarat","family":"Wessagowit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew P.","family":"South","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alistair M.","family":"Robson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy E.","family":"Orchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin A.J.","family":"Eady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"McGrath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0010","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1523-1747.2001.00223.x","article-title":"Differential stromal regulation of MMP-1 expression in benign and malignant keratinocytes","volume":"116","author":"Airola","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0015","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJM200103293441306","article-title":"Cutaneous squamous-cell carcinoma","volume":"344","author":"Alam","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0020","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0945-053X(97)90028-7","article-title":"Matrix metalloproteinases as stromal effectors of human carcinoma progression: Therapeutic implications","volume":"15","author":"Basset","year":"1997","journal-title":"Matrix Biol"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0025","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000184186","article-title":"Insulin-like growth factor binding proteins in the human circulation: A review","volume":"42","author":"Baxter","year":"1994","journal-title":"Horm Res"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0030","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/mp.54.3.145","article-title":"Signalling pathways involved in antiproliferative effects of IGFBP-3: A review","volume":"54","author":"Baxter","year":"2001","journal-title":"Mol Pathol"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0035","first-page":"E450","article-title":"Isolation and characterization of plasmin-generated bioactive fragments of IGFBP-3","volume":"276","author":"Booth","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0040","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0022-5347(01)69892-6","article-title":"Insulin-like growth factor binding protein-3 mediates 1 alpha, 25-dihydroxyvitamin d(3) growth inhibition in the LNCaP prostate cancer cell line through p21\/WAF1","volume":"165","author":"Boyle","year":"2001","journal-title":"J Urol"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0045","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/377646a0","article-title":"Induction of the growth inhibitor IGF-binding protein 3 by p53","volume":"377","author":"Buckbinder","year":"1995","journal-title":"Nature"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0050","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1126\/science.279.5350.563","article-title":"Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study","volume":"279","author":"Chan","year":"1998","journal-title":"Science"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0055","first-page":"3796","article-title":"Clinical significance of insulin-like growth factor-binding protein-3 expression in stage I non-small cell lung cancer","volume":"8","author":"Chang","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0060","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF00917477","article-title":"Patients with severe forms of inherited epidermolysis bullosa exhibit decreased lymphokine and monokine production","volume":"10","author":"Chopra","year":"1990","journal-title":"J Clin Immunol"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0065","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1016-8478(23)15119-3","article-title":"Gene expression profile analysis in human hepatocellular carcinoma by cDNA microarray","volume":"14","author":"Chung","year":"2002","journal-title":"Mol Cells"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0070","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/sj.cdd.4400794","article-title":"DAP-kinase: From functional gene cloning to establishment of its role in apoptosis and cancer","volume":"8","author":"Cohen","year":"2001","journal-title":"Cell Death Differ"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0075","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/carcin\/24.3.393","article-title":"Transcriptional upregulation of the insulin-like growth factor binding protein IGFBP-3 by sodium butyrate increases IGF-independent apoptosis in human colonic adenoma-derived epithelial cells","volume":"24","author":"Collard","year":"2003","journal-title":"Carcinogenesis"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0080","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1046\/j.1365-2230.2003.01210.x","article-title":"Thirty-one cases of Marjolin's ulcer","volume":"28","author":"Copcu","year":"2003","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0085","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1200\/JCO.2001.19.9.2456","article-title":"Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: Multinational phase II\u2013III trial results","volume":"19","author":"Duvic","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0090","first-page":"581","article-title":"Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma","volume":"137","author":"Duvic","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0095","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1200\/JCO.2003.05.068","article-title":"Multicenter phase II study of oral bexarotene for patients with metastatic breast cancer","volume":"21","author":"Esteva","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0100","series-title":"Epidermolysis Bullosa. Clinical, Epidemiologic, and Laboratory Advances and the Findings of the National Epidermolysis Bullosa Registry","first-page":"175","article-title":"Cancer and inherited epidermolysis bullosa: Lifetable analyses of the national epidermolysis bullosa registry study population","author":"Fine","year":"1999"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0105","doi-asserted-by":"crossref","first-page":"3109S","DOI":"10.1093\/jn\/131.11.3109S","article-title":"Insulin, insulin-like growth factors and colon cancer: A review of the evidence","volume":"131","author":"Giovannucci","year":"2001","journal-title":"J Nutr"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0110","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/archderm.1988.01670050081027","article-title":"Tissue stress and promotion. Possible relevance to epidermolysis bullosa","volume":"124","author":"Goldberg","year":"1988","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0115","first-page":"64","article-title":"Growth hormone and prostate cancer: Guilty by association?","volume":"22","author":"Grimberg","year":"1999","journal-title":"J Endocrinol Invest"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0120","first-page":"1545","article-title":"Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells","volume":"56","author":"Gucev","year":"1996","journal-title":"Cancer Res"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0125","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1034\/j.1600-0560.2001.028006277.x","article-title":"Upregulation of P-cadherin expression in the lesional skin of pemphigus, Hailey\u2013Hailey disease and Darier's disease","volume":"28","author":"Hakuno","year":"2001","journal-title":"J Cutan Pathol"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0130","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1016\/S0022-5347(01)63309-3","article-title":"Quantitative immunohistochemical analysis of insulin-like growth factor binding protein-3 in human prostatic adenocarcinoma: A prognostic study","volume":"159","author":"Hampel","year":"1998","journal-title":"J Urol"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0135","doi-asserted-by":"crossref","first-page":"13711","DOI":"10.1074\/jbc.272.21.13711","article-title":"All-trans-retinoic acid increases transforming growth factor-beta2 and insulin-like growth factor binding protein-3 expression through a retinoic acid receptor-alpha-dependent signaling pathway","volume":"272","author":"Han","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0140","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(97)10384-1","article-title":"Circulating concentrations of insulin-like growth factor-I and risk of breast cancer","volume":"1351","author":"Hankinson","year":"1998","journal-title":"Lancet"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0145","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1034\/j.1600-0625.2002.110108.x","article-title":"Comprehensive analysis of gene expression profiles in keratinocytes from patients with generalized atrophic benign epidermolysis bullosa","volume":"11","author":"Huber","year":"2002","journal-title":"Exp Dermatol"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0150","first-page":"137","article-title":"Regulation of insulin-like growth factor (IGF) II and IGF binding protein 3 autocrine loop in human PC-3 prostate cancer cells by vitamin D metabolite 1,25(OH)2D3 and its analog EB1089","volume":"13","author":"Huynh","year":"1998","journal-title":"Int J Oncol"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0155","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/(SICI)1098-1004(1997)10:5<338::AID-HUMU2>3.0.CO;2-B","article-title":"Molecular basis of dystrophic epidermolysis bullosa: Mutations in the type VII collagen gene (COL7A1)","volume":"10","author":"Jarvikallio","year":"1997","journal-title":"Hum Mutat"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0160","first-page":"225","article-title":"Matrix metalloproteinases in squamous cell carcinomas","volume":"15","author":"Johansson","year":"2000","journal-title":"Histol Histopathol"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0165","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/mc.2940060105","article-title":"Relationship between the expression of differentiation-specific keratins 1 and 10 and cell proliferation in epidermal tumors","volume":"6","author":"Kartasova","year":"1992","journal-title":"Mol Carcinogen"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0170","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1128\/MCB.18.3.1642","article-title":"ZIP kinase, a novel serine\/threonine kinase which mediates apoptosis","volume":"18","author":"Kawai","year":"1998","journal-title":"Mol Cell Biol"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0175","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1200\/JCO.2001.19.10.2626","article-title":"Multi-institutional phase I\/II trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancer","volume":"19","author":"Khuri","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0180","first-page":"888","article-title":"Filaggrin distribution in keratoacanthomas and squamous cell carcinoma","volume":"108","author":"Klein-Szanto","year":"1984","journal-title":"Arch Pathol Lab Med"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0185","first-page":"3530","article-title":"Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer","volume":"62","author":"Lee","year":"2002","journal-title":"Cancer Res"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0190","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1677\/joe.0.1750033","article-title":"Nuclear effects: Unexpected intracellular actions of insulin-like growth factor binding protein-3","volume":"175","author":"Lee","year":"2002","journal-title":"J Endocrinol"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0195","doi-asserted-by":"crossref","first-page":"33607","DOI":"10.1074\/jbc.M002547200","article-title":"Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid \u00d7 receptor-alpha regulate transcriptional signaling and apoptosis","volume":"275","author":"Liu","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0200","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/ijc.1539","article-title":"Laminin-5 in the progression of carcinomas","volume":"15","author":"Lohi","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0205","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1046\/j.1365-2230.2002.01130.x","article-title":"Epidermolysis bullosa and cancer","volume":"27","author":"Mallipeddi","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0210","doi-asserted-by":"crossref","first-page":"6483","DOI":"10.1128\/MCB.20.17.6483-6495.2000","article-title":"Human papillomavirus type 16 E7 oncoprotein binds and inactivates growth-inhibitory insulin-like growth factor binding protein 3","volume":"20","author":"Mannhardt","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0215","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1600-0560.1992.tb01352.x","article-title":"Epidermolysis bullosa complicated by squamous cell carcinoma: Report of 10 cases","volume":"19","author":"McGrath","year":"1992","journal-title":"J Cutan Pathol"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0090-4295(01)01004-4","article-title":"Insulin-like growth factor I and prostate cancer","volume":"58","author":"O'Brien","year":"2001","journal-title":"Urology"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0225","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF02778076","article-title":"IGFBPs and neoplastic models. New concepts for roles of IGFBPs in regulation of cancer cell growth","volume":"7","author":"Oh","year":"1997","journal-title":"Endocrine"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0230","doi-asserted-by":"crossref","first-page":"13589","DOI":"10.1074\/jbc.270.23.13589","article-title":"Transforming growth factor-beta-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action","volume":"270","author":"Oh","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0235","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/ijc.10403","article-title":"Laminin-gamma2 overexpression in head-and-neck squamous cell carcinoma","volume":"99","author":"Patel","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0240","first-page":"782","article-title":"The gamma 2 chain of kalinin\/laminin 5 is preferentially expressed in invading malignant cells in human cancers","volume":"145","author":"Pyke","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0245","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1210\/endo.137.7.8770886","article-title":"7S nerve growth factor is an insulin-like growth factor-binding protein protease","volume":"137","author":"Rajah","year":"1996","journal-title":"Endocrinology"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0250","first-page":"163","article-title":"Insulin-like growth factor binding protein-3 mediates necrosis factor-alpha-induced apoptosis: Role of Bcl-2 phosphorylation","volume":"13","author":"Rajah","year":"2002","journal-title":"Cell Growth Differ"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0255","doi-asserted-by":"crossref","first-page":"12181","DOI":"10.1074\/jbc.272.18.12181","article-title":"Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism","volume":"272","author":"Rajah","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0260","first-page":"865","article-title":"Antiproliferative action of necrosis factor-alpha on MCF-7 breast cancer cells is associated with increased insulin-like growth factor binding protein-3 accumulation","volume":"13","author":"Rozen","year":"1998","journal-title":"Int J Oncol"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0265","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/jemt.10173","article-title":"Role of insulin-like growth factor binding protein-3 in breast cancer cell growth","volume":"59","author":"Schedlich","year":"2002","journal-title":"Microsc Res Technol"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0270","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/archderm.1990.01670250084014","article-title":"Recessive dystrophic epidermolysis bullosa skin displays a chronic growth-activated immunophenotype. Implications for carcinogenesis","volume":"126","author":"Smoller","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0275","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/archderm.1989.01670180069008","article-title":"Natural killer cell activity is reduced in patients with severe forms of inherited epidermolysis bullosa","volume":"125","author":"Tyring","year":"1989","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0280","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/jnci\/91.2.151","article-title":"Plasma levels of insulin-like growth factor-I and lung cancer risk: A case\u2013control analysis","volume":"91","author":"Yu","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.0022-202X.2004.22525.x_bb0285","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0022-5347(05)63999-7","article-title":"Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk","volume":"169","author":"Zhao","year":"2003","journal-title":"J Urol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15307958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15307958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T09:41:47Z","timestamp":1705138907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15307958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0022202X15307958"],"URL":"https:\/\/doi.org\/10.1111\/j.0022-202x.2004.22525.x","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}